Grave’s Disease: When to Jump for Operative Management

Abstract

Thyrotoxicosis is mainly due to Grave’s disease, toxic adenoma or multinodular goitre. Management depends on underlying etiology, patients age, patient’s choices and comorbidities. Diagnosis of Grave’s disease can be made clinically but often needs biochemical testing and imaging modalities. Additionally, pros and cons of various available treatment options for Grave’s disease often helps for decision making.  American Thyroid Association (ATA) has given a very clear updated guidelines especially related to Grave’s disease.  This review is based mainly on the ATA guidelines to provide a summary of management for Grave’s thyrotoxicosis.